These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30661720)

  • 1. [Guillain-Barré syndrome to meningococcal conjugate vaccine: Menveo
    Moukafih B; Lachhab Z; Moutaouakkil Y; Fettah H; Ahizoune A; Tadlaoui Y; Bennana A; Lamsaouri J; Bousliman Y
    Therapie; 2019 Sep; 74(4):495-498. PubMed ID: 30661720
    [No Abstract]   [Full Text] [Related]  

  • 2. Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine.
    Ann Pharmacother; 2006 May; 40(5):1007. PubMed ID: 16670362
    [No Abstract]   [Full Text] [Related]  

  • 3. Current safety issues with quadrivalent meningococcal conjugate vaccines.
    Myers TR; McNeil MM
    Hum Vaccin Immunother; 2018 May; 14(5):1175-1178. PubMed ID: 28934061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MCV vaccination in the presence of vaccine-associated Guillain-Barré Syndrome risk: a decision analysis approach.
    Cho BH; Clark TA; Messonnier NE; Ortega-Sanchez IR; Weintraub E; Messonnier ML
    Vaccine; 2010 Jan; 28(3):817-22. PubMed ID: 19879992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, October 2005-February 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Apr; 55(13):364-6. PubMed ID: 16601664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June-July 2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Oct; 54(40):1023-5. PubMed ID: 16224452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alert on meningococcal vaccine.
    FDA Consum; 2005; 39(6):6. PubMed ID: 16669110
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of Guillain-Barré syndrome following serogroup C meningococcal conjugate vaccine in Quebec, Canada.
    De Wals P; Deceuninck G; Boucher RM; Ouakki M
    Clin Infect Dis; 2008 Apr; 46(8):e75-7. PubMed ID: 18444843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination.
    Velentgas P; Amato AA; Bohn RL; Chan KA; Cochrane T; Funch DP; Dashevsky I; Duddy AL; Gladowski P; Greenberg SA; Kramer JM; McMahill-Walraven C; Nakasato C; Spettell CM; Syat BL; Wahl PM; Walker AM; Zhang F; Brown JS; Platt R
    Pharmacoepidemiol Drug Saf; 2012 Dec; 21(12):1350-8. PubMed ID: 22807266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June 2005-September 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Oct; 55(41):1120-4. PubMed ID: 17060898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guillain-Barré syndrome and immunizations.
    Randall DP
    Dis Mon; 2010 May; 56(5):293-8. PubMed ID: 20493307
    [No Abstract]   [Full Text] [Related]  

  • 12. No risk of Guillain-Barré syndrome found after meningococcal conjugate vaccination in two large cohort studies.
    Yih WK; Weintraub E; Kulldorff M
    Pharmacoepidemiol Drug Saf; 2012 Dec; 21(12):1359-60. PubMed ID: 23225672
    [No Abstract]   [Full Text] [Related]  

  • 13. Global Advisory Committee on Vaccine Safety, 12-13 June 2007.
    Wkly Epidemiol Rec; 2007 Jul; 82(28-29):252-9. PubMed ID: 17642098
    [No Abstract]   [Full Text] [Related]  

  • 14. Meningococcal tetravalent conjugate vaccine.
    Smith MJ
    Expert Opin Biol Ther; 2008 Dec; 8(12):1941-6. PubMed ID: 18990080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study.
    Kwong JC; Vasa PP; Campitelli MA; Hawken S; Wilson K; Rosella LC; Stukel TA; Crowcroft NS; McGeer AJ; Zinman L; Deeks SL
    Lancet Infect Dis; 2013 Sep; 13(9):769-76. PubMed ID: 23810252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial commentary: Guillain-Barré syndrome and vaccinations.
    Salmon DA; Halsey NA
    Clin Infect Dis; 2013 Jul; 57(2):205-7. PubMed ID: 23580736
    [No Abstract]   [Full Text] [Related]  

  • 17. Influenza vaccine, Guillain-Barré syndrome, and chasing zero.
    Poland GA; Jacobsen SJ
    Vaccine; 2012 Aug; 30(40):5801-3. PubMed ID: 22883638
    [No Abstract]   [Full Text] [Related]  

  • 18. Global Advisory Committee on Vaccine Safety, 1-2 December 2005.
    Wkly Epidemiol Rec; 2006 Jan; 81(2):15-9. PubMed ID: 16671243
    [No Abstract]   [Full Text] [Related]  

  • 19. Global Advisory Committee on Vaccine Safety, 29-30 November 2006.
    Wkly Epidemiol Rec; 2007 Jan; 82(3):18-24. PubMed ID: 17236262
    [No Abstract]   [Full Text] [Related]  

  • 20. Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence.
    Vellozzi C; Iqbal S; Broder K
    Clin Infect Dis; 2014 Apr; 58(8):1149-55. PubMed ID: 24415636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.